People · Operator
Named in public records as an officer, director or promoter · active 2014–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MINERVA BIOTECHNOLOGIES Corp | — | Biotechnology | Series B | $70.7M | $42.2M | 2014 |
Kenneth Anthony Reed at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kenneth Anthony Reed on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James R. Bridges | 1 | 2 |
| Kenneth Reed | 1 | 2 |
| Cynthia Bamdad | 1 | 1 |
| Robert Staszewski | 1 | 1 |
| Normand Smith | 1 | 1 |
| Normand S Smith | 1 | 1 |
| Joseph Anthony Nathan | 1 | 1 |
| James S Bridges | 1 | 1 |
| Ronald R. Axelrod | 1 | 1 |
| Lawrence Anthony Coolidge | 1 | 1 |
| James F. Bridges | 1 | 1 |
| Normand F. Smith | 1 | 1 |
| Kenneth Kosik | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.